Search Within

Fernando Costa Santini

  1. "Biostatistics Service"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
Groups
  1. Biostatistics Service (7)
  2. Department of Medicine (7)
  3. Epidemiology and Biostatistics (7)
  4. Solid Tumor Oncology Division (7)
  5. Thoracic Oncology (7)
  6. GSK Faculty (6)

More Groups

People
  1. Bob Li (4)
  2. Mark Kris (4)
  3. Afsheen Iqbal (3)
  4. Charles Rudin (3)
  5. Gregory Riely (3)
  6. Isabel Preeshagul (3)

More People

Years
  1. 2024 (3)
  2. 2023 (2)
  3. 2022 (1)
  4. 2018 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Cancer Immunology Research (1)
  3. Clinical Cancer Research (1)
  4. European Journal of Cancer (1)
  5. JCO Precision Oncology (1)
  6. Journal of Thoracic Oncology (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (2)
  3. Elsevier Inc. (2)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer
    Journal Article

    Liu, S. Y.; Erazo, T.; Jee, J.; Arfe, A.; Gupta, A.; Pike, L. R. G.; Santini, F. C.; Daly, B.; Schoenfeld, A.; Eichholz, J.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Clinical and genomic features of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Journal Article

    Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Preeshagul, I.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic predictors of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Meeting Abstract

    Arbour, K. C.; Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Planned interim analysis of a phase II trial of concurrent durvalumab and radiation therapy for locally advanced lung cancer
    Meeting Abstract

    Rimner, A.; Fitzgerald, K.; Iqbal, A. N.; Shepherd, A. F.; Gomez, D. R.; Shin, J. Y.; Gelblum, D. Y.; Hajj, C.; Albrecht, F.; Kotecha, R. R.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of re-treating with immunotherapy after immune-related adverse events in patients with NSCLC
    Journal Article

    Santini, F. C.; Rizvi, H.; Plodkowski, A. J.; Ni, A.; Lacouture, M. E.; Gambarin-Gelwan, M.; Wilkins, O.; Panora, E.; Halpenny, D. F.; Long, N. M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save